Vibegron
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 176 publications
Pharmacologic and clinical considerations of phosphodiesterase type 5 inhibitors and β-adrenergic receptor type 3 agonists for lower urinary tract symptoms and benign prostatic hyperplasia.
Journal: Expert opinion on drug metabolism & toxicology
Published: August 27, 2026
Efficacy of Vibegron in Overactive Bladder: A Bayesian Cross-Trial Synthesis of Benefit Probabilities and Decision Thresholds.
Journal: Lower urinary tract symptoms
Published: June 25, 2026
Sex- and Age-Specific Trends in Prescriptions of Beta-3 Agonists and Anticholinergics in Japan: A Nationwide Prescription Database Study.
Journal: Lower urinary tract symptoms
Published: May 20, 2026
Making the Most of Pharmacologic Interventions: Urodynamic Effects of Different Therapies for Neurogenic Lower Urinary Tract Dysfunction Following Spinal Cord Injury.
Journal: European urology focus
Published: March 23, 2026
Synergistic CRISPR-Cas9 Host Engineering and Enzyme Evolution for Enantioselective Synthesis of a Vibegron Pyrrolidine Intermediate.
Journal: Organic letters
Published: March 16, 2026
Comparing the safety and efficacy of vibegron, mirabegron and tolterodine in patients with overactive bladder: a systematic review and network meta-analysis.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: March 13, 2026
Navigating the challenges of overactive bladder management in women.
Journal: World journal of urology
Published: March 12, 2026
Second- and third-line treatment options for refractory monosymptomatic enuresis in children: a scoping review.
Journal: European journal of pediatrics
Published: February 04, 2026
Real-world persistence of vibegron in patients aged ≥ 80 years with overactive bladder: a multicenter cohort study.
Journal: World journal of urology
Published: February 01, 2026
Editorial Comment: Safety and efficacy of vibegron in pediatric patients with treatment-resistant nocturnal enuresis: a multicenter retrospective study
Journal: International braz j urol : official journal of the Brazilian Society of Urology
Published: January 23, 2026
A novel electrochemical sensor for the analysis of vibegron as a newly approved FDA drug: a rational computational design and cleaning validation application.
Journal: Analytical methods : advancing methods and applications
Published: January 16, 2026
Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative Review.
Journal: Advances in therapy
Published: January 15, 2026
Last Updated: 09/26/2026